C-MER Medical Holdings Limited (HKG:3309)

C-MER Medical Holdings Balance Sheet

Financials in millions HKD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	423.08	512.76	644.7	386.66	553.93
Short-Term Investments	28.98	32.91	31.33	-	-
Trading Asset Securities	15.19	11.75	22.48	55.7	-
Cash & Short-Term Investments	467.25	557.42	698.51	442.36	553.93
Cash Growth	-16.18%	-20.20%	57.90%	-20.14%	3.37%
Accounts Receivable	57.76	53.37	47.13	17.98	14.75
Other Receivables	15.09	13.86	12.94	16.69	1.97
Receivables	72.86	67.23	60.07	34.67	16.72
Inventory	51.94	41.97	55.62	34.46	25.08
Prepaid Expenses	16.79	17.62	11.89	14.76	7.51
Other Current Assets	31.64	35.9	30.47	220.14	7.98
Total Current Assets	640.48	720.14	856.56	746.39	611.23
Property, Plant & Equipment	949.2	992.82	1,058	901.29	784.18
Long-Term Investments	247.29	176.33	116.13	77.39	54.5
Goodwill	440.11	530.43	540.68	194.97	138.52
Other Intangible Assets	259.8	271.76	280.71	8.99	6.41
Long-Term Deferred Tax Assets	4.71	6.82	6.94	10.97	3.13
Other Long-Term Assets	178.57	50.35	43.03	15.88	31.24
Total Assets	2,720	2,749	2,902	1,956	1,629
Accounts Payable	55.81	54.92	45.31	39.87	19.02
Accrued Expenses	131.49	125.81	107.32	64.37	44.34
Short-Term Debt	29.16	1.73	34.26	179.41	-
Current Portion of Long-Term Debt	7.5	7.61	-	-	-
Current Portion of Leases	102.44	107.2	115.08	86.07	67.59
Current Income Taxes Payable	6.51	23.97	18.85	8.54	5.44
Current Unearned Revenue	57.54	54.19	39.49	10.73	8.6
Other Current Liabilities	19.57	13.9	164.5	19.27	7.31
Total Current Liabilities	410.02	389.33	524.8	408.25	152.3
Long-Term Debt	12.42	13.8	21.22	7.6	-
Long-Term Leases	286.27	232.66	281.94	198.62	177.37
Long-Term Deferred Tax Liabilities	64.15	66.22	72.53	0.52	-
Other Long-Term Liabilities	57.38	53.34	2.97	3.66	2.3
Total Liabilities	830.24	755.35	903.45	618.63	331.98
Common Stock	125.56	125.56	126.66	115.03	114.73
Additional Paid-In Capital	1,693	1,693	1,733	1,087	1,072
Retained Earnings	-32.55	103.67	41.68	63.55	64.66
Treasury Stock	-105.73	-46.59	-29.93	-	-
Comprehensive Income & Other	72.8	-29.43	-5.47	65.92	43.24
Total Common Equity	1,753	1,846	1,866	1,331	1,294
Minority Interest	137.23	147.47	132.18	6.01	2.91
Shareholders' Equity	1,890	1,993	1,998	1,337	1,297
Total Liabilities & Equity	2,720	2,749	2,902	1,956	1,629
Total Debt	437.79	362.99	452.49	471.69	244.97
Net Cash (Debt)	29.46	194.43	246.03	-29.33	308.97
Net Cash Growth	-84.85%	-20.97%	-	-	-15.16%
Net Cash Per Share	0.02	0.15	0.20	-0.03	0.28
Filing Date Shares Outstanding	1,221	1,244	1,259	1,236	1,147
Total Common Shares Outstanding	1,221	1,244	1,259	1,150	1,147
Working Capital	230.45	330.81	331.76	338.14	458.92
Book Value Per Share	1.44	1.48	1.48	1.16	1.13
Tangible Book Value	1,053	1,044	1,045	1,127	1,149
Tangible Book Value Per Share	0.86	0.84	0.83	0.98	1.00
Buildings	83.18	86.08	88.44	19.75	19.17
Machinery	462.14	475.16	466.86	337.72	246.99
Construction In Progress	147.94	74.35	26.36	7.9	11.85
Leasehold Improvements	251.31	249.1	235.85	169	102.4

Source: S&P Global Market Intelligence. Standard template. Financial Sources.